ClinicalTrials.gg
Drug

Gadopiclenol clinical trials

Also written P03277 and Elucirem.

studies test it
18
open now
4
in phase 3
6
first study started
2013

How each study uses gadopiclenol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the gadopiclenol studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
21 Sept 2022 · ELUCIREM · NDA 216986 (FDA, Drugs@FDA)
European Union
7 Dec 2023 · Elucirem · EMEA/H/C/005626 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Gadopiclenol
17
Vueway
2

Brand

Elucirem
2

Development codes

P03277
4

Studies by the year they started

18 studies that test it; most in 2025 (3)

Studies that test gadopiclenol, by start year
YearStudies
20131
20161
20172
20181
20192
20211
20221
20232
20242
20253
20262

By phase

A phase 1/2 study counts in both.

Phase 1
4
Phase 2
4
Phase 3
6
Phase 4
4
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 12 · Other 6

Guerbet (12) · University of California, San Diego (1) · M.D. Anderson Cancer Center (1) · UConn Health (1) · Johns Hopkins University (1) · Columbia University (1) · Insel Gruppe AG, University Hospital Bern (1)

Often tested with

Tested in the same studies.

Gadoterate meglumine (1) · Gadobutrol (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test gadopiclenol.

Studies

Open first, then newest update. How each study uses gadopiclenol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 18

Codes

What other systems call gadopiclenol · ClinicalTrials.gg INT001252

  • MeSH (NLM) C000656634gadopiclenolConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) S276568KOYGADOPICLENOLConfirmed FDA, NLM, Wikidata
  • RxNorm 2618720One source FDA
  • Wikidata Q114748523gadopiclenolConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C128640GadopiclenolOne source FDA
  • DrugBank DB17084One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.